ALSにおけるIL-2治療の分層化:バイオマーカーを統合する
1Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Lancet (London, England)
|November 1, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
09:31Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
9.6K
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.7K
